These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8960023)

  • 21. Quantitative AgNOR assessment of cancer cell populations in undifferentiated nasopharyngeal carcinoma.
    Chen M; Lee JC; Lo S
    Anal Quant Cytol Histol; 2002 Apr; 24(2):89-92. PubMed ID: 12026056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell cycle-dependent AgNOR analysis in invasive breast cancer.
    Krüger S; Stahlhut M; Müller H
    Anal Quant Cytol Histol; 2000 Oct; 22(5):358-63. PubMed ID: 11064811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nucleolar organizer regions in benign and malignant prostatic disease.
    Lloyd SN; Johnson CP; Brown IL; Kirk D
    Histopathology; 1991 May; 18(5):449-52. PubMed ID: 1715842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AgNOR counts and histological grade in stage pTa bladder tumours: reproducibility and relation to recurrence pattern.
    Hansen AB; Bjerregaard B; Ovesen H; Horn T
    Histopathology; 1992 Mar; 20(3):257-62. PubMed ID: 1563712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of quantitatively measured AgNORs in ductal mammary carcinoma.
    Aubele M; Auer G; Jütting U; Falkmer U; Gais P
    Anal Quant Cytol Histol; 1994 Jun; 16(3):211-8. PubMed ID: 7522453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Argyrophilic nuclear organizer regions in nasopharyngeal carcinoma and paraneoplastic epithelia.
    Chen M; Lee JC; Lo S; Shen J
    Head Neck; 2003 May; 25(5):395-9. PubMed ID: 12692877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Argyrophilic nucleolar organizer regions in proliferative lesions of the thyroid gland.
    Zaczek M; Szot W; Chłap Z
    Anal Quant Cytol Histol; 1996 Feb; 18(1):1-8. PubMed ID: 8851102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Argyrophilic nucleolar organiser regions (AgNORs) in breast lesions.
    Dasgupta A; Ghosh RN; Sarkar R; Laha RN; Ghosh TK; Mukherjee C
    J Indian Med Assoc; 1997 Sep; 95(9):492-4. PubMed ID: 9529579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Polyethylene glycol-thiosulfate (PEG-Th) staining--a modification of the AgNOR method].
    Löhr CV; Driemeier D; Teifke JP
    Zentralbl Pathol; 1995 Apr; 140(6):465-8. PubMed ID: 7538785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Observer variation in AgNOR counts in neoplastic breast lesions.
    Srivastava A; Agarwal PK; Goel MM; Tandon S; Gupta M; Misra RP
    Anal Quant Cytol Histol; 1996 Jun; 18(3):241-4. PubMed ID: 8790839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AgNOR quantification with special reference to staining patterns.
    Rüschoff J; Fauser G; Knüchel R; Hofstädter F
    Zentralbl Pathol; 1994 Mar; 140(1):23-30. PubMed ID: 7515669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Higher reproducibility of morphometric analysis over the counting method for interphase AgNOR quantification.
    Trerè D; Migaldi M; Trentini GP
    Anal Cell Pathol; 1995 Jan; 8(1):57-65. PubMed ID: 7734412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Argyrophilic nucleolar organizer region in endoscopically obtained biopsy tissue: a useful predictor of nodal metastasis and prognosis in carcinoma of the stomach.
    Kakeji Y; Maehara Y; Orita H; Emi Y; Ichiyoshi Y; Korenaga D; Sugimachi K
    J Am Coll Surg; 1996 Jun; 182(6):482-7. PubMed ID: 8646347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic relevance of silver stained nucleolar organizer region (AgNORs) in benign and malignant breast lesions.
    Agarwal PK; Mehrotra A; Chandra T
    Indian J Exp Biol; 1995 Oct; 33(10):715-20. PubMed ID: 8575800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utility of Argyrophilic nucleolar organizer regions (AgNOR) in differentiating malignant from benign of colorectal tumors.
    Chen LT; Huang MS; Wang YL; Liu CS; Jan CM
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1995 Nov; 11(11):615-20. PubMed ID: 7490794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A multilabeling technique for simultaneous demonstration and quantitation of Ki-67 and nucleolar organizer regions (AgNORs) in paraffin-embedded tissue.
    Munakata S; Hendricks JB
    J Histochem Cytochem; 1994 Jun; 42(6):789-3. PubMed ID: 7514625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of ureteropelvic transitional cell carcinoma with bladder transitional cell carcinoma using an image analyzer.
    Shiina H; Igawa M; Urakami S; Shirakawa H; Ishibe T
    Urol Int; 1996; 56(3):163-8. PubMed ID: 8860737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nucleolar organizer regions in human esophageal disorders: comparison with proliferating cell nuclear antigen by immunostaining.
    Miyazaki S; Sasano H; Suzuki T; Sawai T; Nishihira T; Mori S
    Mod Pathol; 1992 Jul; 5(4):396-401. PubMed ID: 1353881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell adhesion molecule E-cadherin and cellular proliferation marker AgNOR in bladder lesions--usefulness and limitations.
    Menon MM; Simha M
    Indian J Cancer; 1998 Dec; 35(4):142-6. PubMed ID: 10388228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Argyrophilic nucleolar organizer regions in soft tissue tumors.
    Arora HL; Arora N; Solanki RL
    Indian J Pathol Microbiol; 1996 Oct; 39(4):257-63. PubMed ID: 9009475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.